Loading...
Loading...
Among the 4 tracked institutional investors we monitor, BTAI (BIOXCEL THERAPEUTICS INC) is held with a combined value of $825.78K across 559,453 shares. The largest holder is VANGUARD GROUP INC with a position worth $468.40K (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 1 fund increased its holdings. 2 funds reduced their position.
Total Institutional Value
$825.78K
Total Shares Held
559,453
Institutional Holders
4
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $468.40K | 0.00% | New |
| 2 | STATE STREET CORP | $123.44K | 0.00% | +45.7% |
| 3 | FMR LLC | $121.00K | 0.00% | - |
| 4 | BlackRock, Inc. | $112.94K | 0.00% | -0.1% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of BTAI with a position worth $468.40K, representing 0.00% of their portfolio. In total, 4 institutional investors hold BTAI with a combined value of $825.78K.
In the most recent quarter, 1 fund opened a new position in BTAI. Additionally, 1 increased their holdings and 2 reduced their positions.
Institutional investors hold $825.78K worth of BTAI stock across 4 positions. The largest institutional holder is VANGUARD GROUP INC with $468.40K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For BTAI, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their BTAI positions.